Tick-Borne Emerging Infections. Ehrlichiosis and Anaplasmosis

Nahed Ismail, Jere McBride

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Human ehrlichiosis and anaplasmosis are acute febrile tick-borne infectious diseases caused by various members from the genera Ehrlichia and Anaplasma. Ehrlichia chaffeensis is the major etiologic agent of human monocytotropic ehrlichiosis (HME), while Anaplasma phagocytophilum is the major cause of human granulocytic anaplasmosis (HGA). The clinical manifestations of HME and HGA ranges from subclinical to potentially life-threatening diseases associated with mutli-organ failure. Macrophages and neutrophils are the major target cells for Ehrlichia and Anaplasma, respectively. The threat to public health is increasing with newly emerging ehrlichial and anaplasma agents, yet vaccines for human ehrlichioses and anaplasmosis are not available, and therapeutic options are limited. This article reviews recent advances in the understanding of HME and HGA.

Original languageEnglish (US)
JournalClinics in Laboratory Medicine
DOIs
StateAccepted/In press - 2017

Fingerprint

Anaplasmosis
Ehrlichiosis
Tick-Borne Diseases
Anaplasma
Macrophages
Public health
Vaccines
Ehrlichia
Ehrlichia chaffeensis
Anaplasma phagocytophilum
Communicable Diseases
Neutrophils
Fever
Public Health

Keywords

  • Anaplasmosis
  • Diagnosis
  • Ehrlichiosis
  • Immunity
  • Pathogenesis

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Tick-Borne Emerging Infections. Ehrlichiosis and Anaplasmosis. / Ismail, Nahed; McBride, Jere.

In: Clinics in Laboratory Medicine, 2017.

Research output: Contribution to journalArticle

@article{e352797614664d47b7e6abcd1dd75b2f,
title = "Tick-Borne Emerging Infections. Ehrlichiosis and Anaplasmosis",
abstract = "Human ehrlichiosis and anaplasmosis are acute febrile tick-borne infectious diseases caused by various members from the genera Ehrlichia and Anaplasma. Ehrlichia chaffeensis is the major etiologic agent of human monocytotropic ehrlichiosis (HME), while Anaplasma phagocytophilum is the major cause of human granulocytic anaplasmosis (HGA). The clinical manifestations of HME and HGA ranges from subclinical to potentially life-threatening diseases associated with mutli-organ failure. Macrophages and neutrophils are the major target cells for Ehrlichia and Anaplasma, respectively. The threat to public health is increasing with newly emerging ehrlichial and anaplasma agents, yet vaccines for human ehrlichioses and anaplasmosis are not available, and therapeutic options are limited. This article reviews recent advances in the understanding of HME and HGA.",
keywords = "Anaplasmosis, Diagnosis, Ehrlichiosis, Immunity, Pathogenesis",
author = "Nahed Ismail and Jere McBride",
year = "2017",
doi = "10.1016/j.cll.2017.01.006",
language = "English (US)",
journal = "Clinics in Laboratory Medicine",
issn = "0272-2712",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Tick-Borne Emerging Infections. Ehrlichiosis and Anaplasmosis

AU - Ismail, Nahed

AU - McBride, Jere

PY - 2017

Y1 - 2017

N2 - Human ehrlichiosis and anaplasmosis are acute febrile tick-borne infectious diseases caused by various members from the genera Ehrlichia and Anaplasma. Ehrlichia chaffeensis is the major etiologic agent of human monocytotropic ehrlichiosis (HME), while Anaplasma phagocytophilum is the major cause of human granulocytic anaplasmosis (HGA). The clinical manifestations of HME and HGA ranges from subclinical to potentially life-threatening diseases associated with mutli-organ failure. Macrophages and neutrophils are the major target cells for Ehrlichia and Anaplasma, respectively. The threat to public health is increasing with newly emerging ehrlichial and anaplasma agents, yet vaccines for human ehrlichioses and anaplasmosis are not available, and therapeutic options are limited. This article reviews recent advances in the understanding of HME and HGA.

AB - Human ehrlichiosis and anaplasmosis are acute febrile tick-borne infectious diseases caused by various members from the genera Ehrlichia and Anaplasma. Ehrlichia chaffeensis is the major etiologic agent of human monocytotropic ehrlichiosis (HME), while Anaplasma phagocytophilum is the major cause of human granulocytic anaplasmosis (HGA). The clinical manifestations of HME and HGA ranges from subclinical to potentially life-threatening diseases associated with mutli-organ failure. Macrophages and neutrophils are the major target cells for Ehrlichia and Anaplasma, respectively. The threat to public health is increasing with newly emerging ehrlichial and anaplasma agents, yet vaccines for human ehrlichioses and anaplasmosis are not available, and therapeutic options are limited. This article reviews recent advances in the understanding of HME and HGA.

KW - Anaplasmosis

KW - Diagnosis

KW - Ehrlichiosis

KW - Immunity

KW - Pathogenesis

UR - http://www.scopus.com/inward/record.url?scp=85016014815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016014815&partnerID=8YFLogxK

U2 - 10.1016/j.cll.2017.01.006

DO - 10.1016/j.cll.2017.01.006

M3 - Article

JO - Clinics in Laboratory Medicine

JF - Clinics in Laboratory Medicine

SN - 0272-2712

ER -